GlassScriptPhysician profile
Erin E Tenney
NPI 1669893848
$7,568.34
in general payments reported to CMS, 2019-2025
26 companies · $649 in 2025
The $649 reported for 2025 was more than what 84% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $425 · 2022: $4,067 · 2023: $1,017 · 2024: $1,410 · 2025: $649.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,020 · Debt Forgiveness: $55.76.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,020.09 |
| Debt Forgiveness | $55.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,126.12 | 2021-2025 | Linq II, Micra, Symplicity G3 |
| Abbott Laboratories | $929.80 | 2021-2025 | Gallant, Assurity, Merlin@Home |
| Merck Sharp & Dohme LLC | $514.24 | 2022-2025 | Verquvo |
| Pfizer INC. | $369.12 | 2021-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $357.29 | 2021-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $256.50 | 2022-2025 | Camzyos, Eliquis |
| Novartis Pharmaceuticals Corporation | $252.94 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $226.07 | 2022-2025 | Jardiance |
| Boston Scientific Corporation | $175.34 | 2024-2025 | Watchman Flx, Emblem Mri S-Icd |
| Atricure, INC. | $148.47 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $144.29 | 2022-2023 | Andexxa |
| Esperion Therapeutics, INC. | $129.36 | 2022-2024 | Nexletol |
| Amgen INC. | $129.14 | 2022-2025 | Repatha |
| Abiomed | $124.30 | 2024 | Impella |
| Heartflow, INC. | $120.86 | 2022-2023 | Ffrct |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Itamar Medical INC | $110.41 | 2024 | Watchpatone |
| Biosense Webster, INC. | $83.62 | 2022-2023 | Carto 3 |
| Scpharmaceuticals INC. | $79.94 | 2023-2024 | |
| Janssen Pharmaceuticals, INC | $66.01 | 2021-2023 | Xarelto |
| Baxter Healthcare | $55.76 | 2023 | |
| Azurity Pharmaceuticals, INC. | $48.00 | 2024-2025 | Edarbi |
| Cvrx, INC. | $37.78 | 2024 | Barostim Neo System |
| Endologix LLC | $23.48 | 2022 | |
| Lilly USA, LLC | $20.94 | 2025 | Zepbound |
| Inspire Medical Systems, INC. | $19.64 | 2025 | Inspire |
| Impulse Dynamics (USA) INC. | $18.92 | 2023 | Optimizer |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Tenney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.